|
Listener feedback on PFA and STEMI/NSTEMI paradigm, oral semaglutide, symptomatic vs asymptomatic AF, and the win-ratio are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I. Listener Feedback Oct 18, 2024 This Week in Cardiology Podcast https://www.medscape.com/viewarticle/1001769 https://www.hrsonline.org/guidance/safety-alerts/boston-scientific-cardiac-cryoablation-system - STEMI/NSTEMI https://doi.org/10.1016/j.jacadv.2024.101314
II. Oral Semaglutide - Press Release: https://www.novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-details.html?id=171480
- Rationale Paper SOUL trial
III. Symptomatic vs Asymptomatic AF - Meta-analysis in EHJ
-
- Meta-analysis of rate vs rhythm-control strategies https://doi.org/10.1016/j.jacep.2024.03.006
IV. The Win Ratio - Pocock and colleagues https://doi.org/10.1093/eurheartj/ehae647
You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net |